How Has Brexit Affected Pharmaceutical Distribution in the UK?

Electronic Health Reporter

The article How Has Brexit Affected Pharmaceutical Distribution in the UK? Editorial Brexit pharmaceutical distribution UKThis article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited.

Workforce training platform Transform launches to the pharmaceuticals industry

Mobi Health News

The platform provides solutions in energy health and safety training and now brings its training expertise to the pharmaceuticals sector

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Protecting the pharmaceutical supply chain

Mobi Health News

Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. Blockchain is an electronic cryptographic ledger which creates an immutable record of all events throughout the supply chain, allowing digital information to be distributed without being copied

How Pharmaceutical Companies Can Take Advantage of the EHR Revolution

Electronic Health Reporter

The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter. The 21st century has seen a massive change in the way people live their lives. It is now the digital era, and almost everything is online or made available in electronic form. There are now jobs online.

Pimping the pharmaceutical supply chain

Mobi Health News

Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. Blockchain is an electronic cryptographic ledger which creates an immutable record of all events throughout the supply chain, allowing digital information to be distributed without being copied

New pharmaceutical track and trace system announced for Bahrain

Mobi Health News

The aim of the electronic system is to ensure medicines are dispensed according to the correct procedures set by authorities, as well as to prevent counterfeit drugs

New Pharmaceuticals For 2020 and Beyond

Electronic Health Reporter

From rheumatoid arthritis to HIV, the pharmaceutical industry is well on its way to making this a banner year for new drug implementation. The article New Pharmaceuticals For 2020 and Beyond appeared first on electronichealthreporter.com. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited. Here are just a few exciting breakthroughs for big pharma in 2020. […].

Teva Pharmaceuticals releases its prescription ProAir Digihaler in the US

Mobi Health News

The connected inhaler's launch will be followed by Teva's other Digihaler products before the end of the year

Teva Pharmaceutical's AirDuo Digihaler gets FDA green light

Mobi Health News

The technology has a built-in sensor that can send usage data to a corresponding smartphone app.

Industry Voices—Pharmaceutical supply chain adjustments to outlast COVID-19

FierceHealthIT

Industry Voices—Pharmaceutical supply chain adjustments to outlast COVID-19. hlandi. Mon, 09/14/2020 - 13:43

Recursion Pharmaceuticals' $239M for AI drug discovery, optimize.health's $15.6M for remote patient monitoring and more digital health fundings

Mobi Health News

Also: Skin Analytics' Series A contributes to AI-based detection of potential skin cancer; China's LickDoc supports its healthcare big data repository with $102 million

New Tech Tonics Podcast Episode: Sean Khozin: Attuned To Data Science

Digital Health

Biotech and Genetics Digital Health Entrepreneurship Healthcare Information Technology Innovation Tech Tonics Podcast data science INFORMED initiative iranian immigration Janssen Pharmaceuticals Manatt Health Sean Khozin

From Pharmaceuticals to Medical Devices: What to Watch in China's Healthcare Sector

Lloyd Price

In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People The Chinese government estimates that spending in its healthcare sector will reach $2.3

Europe’s largest initiative to accelerate therapy development for COVID-19 launched

Mobi Health News

The CARE consortium will accelerate R&D by bringing together expertise from research institutions and pharmaceutical companies

Americans Worry About Medical Bankruptcy, With Prescription Drug Costs Also Playing Into Voters’ Concerns

Health Populi

One in two people in the U.S. are concerned that a major health event in their family would lead to bankruptcy, up 5 percent points over the past eighteen months.

Pharma’s Future Relevance Depends on Empathy, Messaging, Partnering, and Supporting Patients and Providers

Health Populi

COVID-19 is re-shaping all industries, especially health care. And the pharma industry is challenged along with other health care sectors.

Harnessing Innovation to Serve and Create Value for Patients

Electronic Health Reporter

By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter. Innovation is not a choice but rather a growth mindset, which creates an environment for building a sustainable business. This mindset allows for objectivity and contributions towards a bigger shared purpose.

AHIP18: How Intermountain plans to fight pharmaceutical monopolies as a generic drugmaker

FierceHealthIT

After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset

Pharmacies Grow for Primary Care On-Ramps – And J.D. Power Says Consumers Like That

Health Populi

Consumer experience Coronavirus COVID-19 Health and Beauty Health Consumers Health ecosystem Medication adherence Patient experience Pharmaceutical Pharmacy Prescription drugs Prevention Prevention and wellness Primary care Retail health Self-care Travel and health Wellness

Wasted: $1 of Every $4 Spent on Health Care In America

Health Populi

Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. How that demand side will reconcile with the supply side of pharmaceutical and life science companies, health insurers, retail pharmacy, hospitals and physicians — all strong and assertive lobbies inside the Beltway — will become clearer over the next thirteen months.

The Racial Divide Due to COVID-19 Also Applies to Healthcare and Pharma Costs

Health Populi

Coronavirus COVID-19 Death Demographics and health Financial health Financial wellness Health citizenship Health Consumers Health costs Health disparities Health Economics Health equity Medicines Pharmaceutical Prescription drugs Race and health Social determinants of health

Health industry responds to European Innovation Partnership proposal

Mobi Health News

Industry leaders across medtech and pharmaceutical sectors applaud proposal for its forward thinking

On Amazon Prime Day, What Could Health Care Look Like?

Health Populi

Banks and health Beauty and health Consumer experience Design and health Grocery stores Health and Beauty Health care marketing Health Consumers Health costs Health ecosystem Health engagement Health marketing High deductibles Medical banking Medicines Money and health Patient experience Pharmaceutical Pharmacy Popular culture and health Prescription drugs Retail health Self-care Shopping and health Sleep Transparency Travel and health Trust User experience UX Wellbeing Wellness Workflow

Health Care and Consumers in 2030: A Profile from KPMG

Health Populi

A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and Life Sciences Institute. In Healthcare 2030: The consumer at the center , the KPMG team explores the demographic shifts and market drivers that will challenge the health care industry in the current U.S. delivery and financing system.

Listen Up, Healthcare: Hear The Patient’s Voice!

Health Populi

Connected health Consumer experience Consumer-directed health Financial health Financial wellness Health Consumers Health costs Health Economics Health engagement Health social networks High deductibles Patient engagement Patient experience Pharmaceutical Prescription drugs Social networks and health Specialty drugsConsider the voice of a patient before the advent of the Internet in the digital 1.0 world, and then the proliferation of social networks in v 2.0.

Patients Growing Health Consumer Muscles Expect Digital Services

Health Populi

Patients’ experiences with the health care industry fall short of their interactions with other industries — namely online retail, online banking and online travel, a new survey from Cedar, a payments company, learned. Survata conducted the study for Cedar among 1,607 online U.S. consumers age 18 and over in August and September 2019. These study respondents had also visited a doctor or hospital and paid a medical bill in the past year.

The New Drug Companies Aren’t Drug Companies At All

Health Populi

In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. Artificial intelligence Big data and health Bio/life sciences Biotech Data analytics and health Health care industry Health ecosystem Health insurance Medicare Medicines Personalized medicine Pharmaceutical Venture capital and health

How COVID-19 Has Re-Shaped Health Care Delivery So Far

Health Populi

Consumer experience Coronavirus COVID-19 Employee benefits Health care industry Health Consumers Health costs Health ecosystem Health engagement Health insurance Healthcare access Medication adherence Medicines Mental health Oncology Patient engagement Pharmaceutical Pharmacy Physicians Prescription drugs Shopping and health Telehealth TelemedicineCOVID-19 is re-shaping health care in America across many dimensions.

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

Bio/life sciences Financial toxicity Health Consumers Health costs Health policy Health politics media and health Medicaid Medicare Medicines Pharmaceutical Pharmacy Prescription drugs Retail health Specialty drugs Transparency Women and healthNine in ten Americans is concerned about the price of prescription drugs in the wake of the coronavirus pandemic, Gallup and West Health found in their survey on the cost of healthcare, published today.

Pfizer working with Finnish tech startup to improve patient adherence

Mobi Health News

The pharmaceutical giant will offer Popit’s pill detection device to rheumatoid arthritis patients

Most Americans Blame Drug Companies, Insurers, and Hospitals for High Health Care Costs

Health Populi

Health Consumers Health costs Health Economics Health insurance Health Plans Health policy Health politics Hospitals Pharmaceutical Prescription drugsThere’s little agreement between Democrats and Republicans on a plethora of issues in American public life. But one issue that brings U.S. citizens together is agreement that the cost of health care is too high in the country, and that pharma, health plans, and providers are to blame.

Americans’ Concerns About the US Healthcare System Loom Larger Than Worries About Their Own Care

Health Populi

Bio/life sciences Business and health Coronavirus COVID-19 Education and health Health benefits Health care industry Health citizenship Health Consumers Health costs Health ecosystem Health insurance Health Plans Health policy Health politics media and health Medical innovation Medicines Money and health Personal health finance Pharmaceutical Pre-existing conditions Prescription drugs Public health SDoH Shared decision making Social determinants of health Universal health care Wellbeing

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. People in the U.S.

Despite Greater Digital Health Engagement, Americans Have Worse Health and Financial Outcomes Than Other Nations’ Health Citizens

Health Populi

The idea of health care consumerism isn’t just an American discussion, Deloitte points out in its 2019 global survey of healthcare consumers report, A consumer-centered future of health. The driving forces shaping health and health care around the world are re-shaping health care financing and delivery around the world, and especially considering the growing role of patients in self-care — in terms of financing, clinical decision making and care-flows.

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. In fact, if you knew that the business model of PLM was always to package and sell data to researchers, including the pharmaceutical industry, you may shrug your shoulders and assume there is no fundamental change. By Susannah Fox, Jane Sarasohn-Kahn and Lisa Suennen.

Health Care In the COVID-19 Era – PwC Finds Self-Rationing of Care and Meds Especially for Chronic Care

Health Populi

Chronic care Chronic disease Coronavirus COVID-19 Diabetes Digital health Health at home Health benefits Health care industry Health Consumers Health engagement Health finance Health insurance Health Plans Health policy Heart disease Home care Hospital finance Hospitals medical home Medicare Medication adherence Medicines Mental health Pharmaceutical Pharmacy Prescription drugs Prevention and wellness Primary care Self-care Telehealth Telemedicine Virtual healthPatients in the U.S.

Americans’ Trust in U.S. Healthcare Lags Tech — and Women Are Particularly Cynical

Health Populi

Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. “informed public” and the mass population. Fewer American women, too, trust the healthcare industry than men do.

In 2023, the U.S. Will Still Be the #1 Prescription Drug Spender in the World, IQVIA Forecasts

Health Populi

Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugsToday, as Congress kicks off hearings about the cost of prescription drugs in the United States, IQVIA published its 2019 report on The Global Use of Medicine in 2019 and Outlook to 2023. The top-line of the research is the robust pharma market growth will be driven by two factors, and limited by two others: spending in the U.S.

National Health Spending Will Reach Nearly 20% of U.S. GDP By 2027

Health Populi

Behavior change Diabetes Employee benefits Employers Health benefits Health Consumers Health costs Health Economics Health engagement Health insurance Health politics Health reform Healthcare access Heart health HIV/AIDS Hospitals Loneliness Medicaid Medicare Medicines Money and health Personal health finance Pharmaceutical Prescription drugs Public health Seniors and health Social determinants of health Universal health careNational health spending in the U.S. is expected to grow by 5.7%

Employers Take on Health Activism, Embracing Behavioral Health, Virtual Care, AI, and Transparency

Health Populi

One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S.